|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ͷ������ |
|
��Ⱦ |
|
Ƥ���� |
| ��������������� | |
|
���� |
|
������ |
| PubMed | |
|
Article by ���� |
|
Article by ������ |
HPV��Ⱦ��Ƥ����
����1, ������2
1. �ӱ�ʯ��ׯ�侯�ӱ��ܶ�ҽԺƤ���� 050081;
2. ���ľ�ҽ��ѧ����ҽԺƤ����
ʵ���о�֤ʵ,Ƥ������֯�пɼ�����ͷ������DNA,�ر�������ͷ������16/18��.����ͷ������16�͵Ļ������E6��E7�������������Ƶ���p53��PRb���,ʹp53ɥʧ������DNA��������,��������ͷ���������Եĺ���������Ԥ��.����ͷ��������Ⱦ�ɼ���Ƥ�����Ķ��Զ�.������Ƥ����������������ͷ��������Ⱦ�������.
1. �ӱ�ʯ��ׯ�侯�ӱ��ܶ�ҽԺƤ���� 050081;
2. ���ľ�ҽ��ѧ����ҽԺƤ����
1. �ӱ�ʯ��ׯ�侯�ӱ��ܶ�ҽԺƤ���� 050081;
2. ���ľ�ҽ��ѧ����ҽԺƤ����
[2] de Villiers EM.Human papillomavirus infections in skin cancers.Biomed Pharmacother,1998,52(1):26-33.
[3] Cheah PL,Looi LM.Biology and pathological associations of the human papillomaviruses:a review.Malays J Pathol,1998,20(1):1-10.
[4] Lungu O,Sun XW,Wright TC Jr,et al.A polymerase chain reaction-en-zyme-linked immunosorbent assay method for detecting human papillo-mavirus in cervical carcinomas and high-grade cervical cancer precursors.Obstet Gynecol,1995,85(3):337-342.
[5] Beikhout RJ,Bouwes Bavinck JN,ter Schegget J.Persistence of human papillomavirus DNA in benign and(pre)malignant skin lesions from renal transplant recipients.J Clin Microbiol,2000,38(6):2087-2096.
[6] Pierceal WE,Goldberg LH,Ananthaswamy HN.Presence of human pa-pilloma virus type 16 DNA sequences in human nonmelanoma skin cancers.J Invest Dermatol,1991,97(5):880-884.
[7] Mueller N.Overview of the epidemiology of malignancy in immune deficiency.J Acquit Immune Defic Syndr,1999,21(Suppl 1):S5-S10.
[8] Shamanin V,zur Hausen H,Lavergne D,et al.Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and noninmmunosuppressde patients.J Nail Cancer Inst,1996,88(12):802-811.
[9] Dreau D,Culberson C,Wyatt S,et al.Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression.Ann Surg,2000,231(5):664-671.
[10] Takamiyagi A,Asato T,Nakashima Y,et al.Association of human papil-lomavirus type 16 with malignant melanoma.Am J Dermatopathol,1998,20(1):69-73.
[11] Sanchez-Lanier M,Triplett C,Campion M.Possible role for human papil-lomavirus,16 in spuamous cell carcinoma of the finger.J Med Viral,1994,44(4):369-378.
[12] Thomas JT,Laimins LA.Human papillomavirus onceproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.J Virol,1998,72(2):1131-1137.
[13] Harwoed CA,McGregor JM,Proby CM,et al.Human papillomavirus and the development of non-melanoma skin cancer.J Clin Pathol,1999,52(4):249-253.
[14] Dreau D,Hogg M,Foster M,et al.Presence and effects of human papilloma virus oncoproteins on cell cycle protein expression and growth of melanoma cells in vitro.Prec Am Assoc Cancer Res,1999,40:573.
[15] Havre PA,Yuan J,Hedrick L,et al.p53 inactivation by HPV16 E6 resuits in increased mutagenesis in human cells.Cancer Res,1995,55(19):4420-4424.
[16] Martin LG,Demers GW,Galloway DA.Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.J Virol,1998,72(2):975-985.
[17] Foster SA,Galloway DA.Human papillomavinrus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells.Once-gone,1996,12(8):1773-1779.
[18] Alvarez-Salas LM,Cullinan AE,Siwkowski A,et al.Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.Proc Natl Acad Sci U S A,1998,95(3):1189-1194.
[19] Hennig EM,Nesland JM,Di Lonardo A,et al.Multiple primary cancers and HPV infection:are they related? J Exp Clin Cancer Res,1999,18(1):53-54.
[20] Severson J,Evans TY,Lee P,et al.Human papillomavirus infections:epidemiology,pathogenesis,and therapy.J Cutan Med Surg,2001,5(1):43-60.